Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Meda AB Completes Acquisition of Acton Pharmaceuticals

Monday, 21 Oct 2013 02:00am EDT 

Meda AB announced that the acquisition of Acton Pharmaceuticals, Inc. and its proprietary product Aerospan, has now been completed. The purchase price for Acton amounted to USD 135 million, on a cash and debt free basis. In addition, there is a milestone payment of USD 10 million and royalty based milestones. 

Company Quote

26 Mar 2015